Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, South-1, West-16, Chuo-ku, Sapporo, 060-8543, Japan.
J Bone Miner Metab. 2013 Jul;31(4):399-408. doi: 10.1007/s00774-013-0436-y. Epub 2013 Apr 16.
Tetranectin is a plasminogen-binding protein that enhances plasminogen activation, which has been suggested to play a role in tissue remodeling. Recently, we showed that tetranectin has a role in the wound-healing process. In this study, we investigated whether tetranectin plays a role in fracture healing. The fracture-healing process was studied using a femoral osteotomy model in tetranectin-null mice, previously generated by the authors. Radiographic imaging, micro-computed tomography (μCT), and histological analysis were used to evaluate osteotomy healing. In wild-type mice, a callus was apparent from 7 days, and most samples showed marked callus formation and rebridging of the cortices at the osteotomy site at 21 days. In contrast, in the tetranectin-null mice there was no callus formation at 7 days and much less callus formation and no bridging of cortices were observed at 21 days. At 35 days, all osteotomy sites showed clear rebridging, and secondary bone formation was achieved in wild-type mice by 42 days. In contrast, no clear rebridging or secondary bone formation was observed at 42 days in the tetranectin-null mice. Analysis using μCT at 21 days after osteotomy revealed that the callus area in tetranectin-null mice was smaller than that in wild-type mice. Histological analysis also showed that soft tissue and callus formation were smaller in the tetranectin-null mice at the early stage of the healing process after drill-hole injury. These results suggested that tetranectin could have a role in the positive regulation at the early stage of the fracture-healing process, which was reflected in the delayed fracture healing in tetranectin-deficient mice.
纤连蛋白四聚糖是一种纤溶酶原结合蛋白,可增强纤溶酶原的激活,这被认为在组织重塑中发挥作用。最近,我们表明纤连蛋白四聚糖在伤口愈合过程中发挥作用。在这项研究中,我们研究了纤连蛋白四聚糖是否在骨折愈合中发挥作用。使用作者先前生成的纤连蛋白四聚糖缺失小鼠的股骨切开模型研究骨折愈合过程。使用放射成像、微计算机断层扫描(μCT)和组织学分析来评估切开愈合。在野生型小鼠中,从第 7 天开始出现骨痂,并且大多数样本在第 21 天显示出明显的骨痂形成和切开部位皮质的重新桥接。相比之下,在纤连蛋白四聚糖缺失小鼠中,第 7 天没有骨痂形成,并且观察到的骨痂形成较少,并且皮质没有桥接。第 35 天,所有切开部位均显示明显的重新桥接,并且野生型小鼠在第 42 天实现了二次骨形成。相比之下,在第 42 天,纤连蛋白四聚糖缺失小鼠中没有观察到明显的重新桥接或二次骨形成。在切开后第 21 天使用 μCT 分析表明,纤连蛋白四聚糖缺失小鼠的骨痂面积小于野生型小鼠。组织学分析还表明,在钻孔损伤后愈合过程的早期,纤连蛋白四聚糖缺失小鼠的软组织和骨痂形成较小。这些结果表明,纤连蛋白四聚糖可能在骨折愈合过程的早期的正调控中发挥作用,这反映在纤连蛋白四聚糖缺乏小鼠骨折愈合延迟。